Atlanta Endocrine Associates

Our paper on the identification of high-risk patients with NAFLD/MASLD in endocrinology clinics. Free download via this author link.
https://authors.elsevier.com/c/1hrTF_,3UnYHv6r

Dr. Isaacs was interviewed for this story for CBS Evening News about

Eli Lilly seeks FDA approval for weight loss drug tirzepatide Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be s...

Reproductive aged women have lower rates of NAFLD compared with men; however, NAFLD prevalence in postmenopausal women is similar to or exceeds that in men. https://www.healio.com/news/womens-health-ob-gyn/20230109/odds-of-nonalcoholic-fatty-liver-disease-greater-after-menopause

Recommendations to enable and optimize a multidisciplinary approach in NAFLD care.

Thread by @scottisaacsmd on Thread Reader App : Recommendations to enable and optimize a multidisciplinary approach in care. nature.com/articles/s4385… Evaluate benefit and cost-effective...…

It was such an honor to be part of the first annual Canadian NAFLD & NASH Summit. Here is a recording of my presentation about the relationship between NAFLD/NASH and Type 2 Diabetes, obesity, cardiovascular risk.

Video 9: Dr. Scott Isaacs NAFLD/NASH and the relationship to Type-2 Diabetes, Obesity & Cardiovascular Risk with Dr. Scott Isaacs, Endocrinologist.

Twittorial about the link between fatty liver and heart disease. https://threadreaderapp.com/thread/1601962266315874311.html

Reversing fatty liver disease is a key factor in diabetes remission.

Nonalcoholic Fatty Liver Disease Endocrinology and Metabolism Clinics of North AmericaAvailable online 18 November 2022In Press, Corrected ProofWhat are Corrected Proof articles?Nonalcoholic Fatty Liver DiseaseAuthor links open overlay panelScottIsaacsMDabShow moreShareCitehttps://doi.org/10.1016/j.ecl.2022.06.007Get rights and con...